by Sjogren’s syndrome is an autoimmune disease that causes dry eyes and mouth. It occurs when the immune system attacks and destroys the glands that produce tears and saliva. The disease can potentially lead to chronic dryness, discomfort, and eye and dental problems. Diagnostic tests for Sjogren’s syndrome include blood tests, eye exams, saliva tests, and lip biopsy. Treatment focuses on relieving symptoms with artificial tears and saliva, supplements, eye protection, dental care, muscle relaxants, antidepressants, and immunosuppressants.
The global Sjogren’s Syndrome Market is estimated to be valued at US$ 242.81 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Rising prevalence of Sjogren’s syndrome is the major driver boosting growth of the market. Sjogren’s syndrome is one of the most common autoimmune diseases with an estimated worldwide prevalence rate of 0.5-3%. It is more prevalent in women over the age of 40 years, with a female-to-male ratio of 9:1. Increasing awareness about early diagnosis and treatment of the disease is also expected to aid market growth. For instance, routine screening of high-risk groups can help improve disease management and outcomes. Additionally, ongoing research and clinical trials focusing on development of new drugs for improved treatment is fueling the market. Some late stage pipeline drugs under evaluation include tertacamra and belimumab. However, lack of definitive diagnostic tests poses a challenge for the market. Since symptoms mimic other common conditions, it sometimes leads to delayed or misdiagnosis of Sjogren’s syndrome.
Segment Analysis
The global Sjogren’s syndrome market can be segmented based on disease type, treatment, distribution channel, and geography. By disease type, the market is segmented into primary Sjogren’s syndrome and secondary Sjogren’s syndrome. The primary Sjogren’s syndrome segment dominates currently due to increasing cases being reported across the world yearly. By treatment, the market is divided into medications, eye care, oral care, and others. The medications segment holds the largest share as it is the major form of treatment prescribed for symptoms relief.
PEST Analysis
Political: Governments across various countries are raising awareness and funding research activities for rare diseases like Sjogren’s syndrome through favorable regulations.
Economic: Rising healthcare expenditures to improve diagnostics and treatment availability for chronic diseases like Sjogren’s syndrome is boosting market revenues.
Social: Growing social support through patient advocacy groups is educating people and reducing the stigma around autoimmune disorders.
Technological: Advancements in biosensors, digital imaging, and biomarkers are enabling early detection and improved disease management approaches for Sjogren’s syndrome.
Key Takeaways
The global Sjogren’s Syndrome Market Share is expected to witness high growth. The global Sjogren’s syndrome market is estimated to be valued at US$ 242.81 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030.
North American region currently dominates the global market and is expected to continue its dominance in the forecast period owing to established healthcare infrastructure and increasing awareness levels in the region.
Key players operating in the Sjogren’s syndrome market are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation. Key regional players focused on strategic collaborations to strengthen product portfolios and geographic footprints is expected to provide significant opportunities for market players over the forecast period.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
